Company profile
NAXIA Discovery
A unique and innovative technology platform for next-generation oligonucleotide therapeutics
- Industry
- Biotechnology Research
- Employees
- 4
- Headquarters
- Marseille, Provence-Alpes-Côte d'Azur
- Founded
- 2025
- LinkedIn followers
- 374
- Office locations
- 3
NAXIA Discovery company summary
NAXIA Discovery is a company in the Biotechnology Research industry, headquartered in Marseille, Provence-Alpes-Côte d'Azur, founded in 2025. On LinkedIn the company has around 4 employees and 374 followers. The company lists 3 office locations. Its listed specialties include Drug Discovery, Oligonucleotides, TechBio, ASO, siRNA.
What technology does NAXIA Discovery use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NAXIA Discovery
NAXIA Discovery (formerly IASO Discovery) is a TechBio company developing a chemistry-driven oligonucleotide discovery platform applicable across multiple therapeutic areas. Built as a spin-off from over 20 years of academic and translational research, NAXIA combines deep expertise in oligonucleotide chemistry with a proprietary discovery platform spanning design, synthesis, conjugation, and formulation. NAXIA Discovery operates an open and collaborative platform, partnering with academic institutions, biotechs, and industry players through services, co-development, licensing, and spin-off creation. A core technology enabled by the platform is a first-in-class synthetic G-quadruplex approach that introduces a novel mechanism of action to modulate oncogenic gene expression, offering new therapeutic possibilities for treatment-resistant cancers. With strong scientific leadership and a hybrid business model, NAXIA Discovery aims to become a European reference in oligonucleotide drug discovery and innovation.
Specialties
Where is NAXIA Discovery located?
NAXIA Discovery lists 3 office locations.
Compare companies similar to NAXIA Discovery
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NAXIA Discovery naxia-discovery.com | Biotechnology Research | 4 | 2025 | Marseille, Provence-Alpes-Côte d'Azur |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about NAXIA Discovery
What does NAXIA Discovery do?
NAXIA Discovery (formerly IASO Discovery) is a TechBio company developing a chemistry-driven oligonucleotide discovery platform applicable across multiple therapeutic areas. Built as a spin-off from over 20 years of academic and translational research, NAXIA combines deep expertise in oligonucleotide chemistry with a proprietary discovery platform spanning design, synthesis, conjugation, and formulation. NAXIA Discovery operates an open and collaborative platform, partnering with academic institutions, biotechs, and industry players through services, co-development, licensing, and spin-off creation. A core technology enabled by the platform is a first-in-class synthetic G-quadruplex approach that introduces a novel mechanism of action to modulate oncogenic gene expression, offering new therapeutic possibilities for treatment-resistant cancers. With strong scientific leadership and a hybrid business model, NAXIA Discovery aims to become a European reference in oligonucleotide drug discovery and innovation.
How many employees does NAXIA Discovery have?
NAXIA Discovery has around 4 employees on LinkedIn.
Where is NAXIA Discovery headquartered?
NAXIA Discovery is headquartered in Marseille, Provence-Alpes-Côte d'Azur.
Where does NAXIA Discovery have offices?
NAXIA Discovery lists 3 office locations, including Marseille, Provence-Alpes-Côte d'Azur, FR; Bordeaux, 33000, FR; Paris, 75015, FR.
When was NAXIA Discovery founded?
NAXIA Discovery was founded in 2025.
Build a lead list from companies like NAXIA Discovery
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.